CELLESTIAL HEALTH LTD

Active United Kingdom

Research and experimental development on biotechnology

1 employees website.com
Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
C

CELLESTIAL HEALTH LTD

Research and experimental development on biotechnology

Founded 18 Apr 2023 Active United Kingdom 1 employees website.com
Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
Accounts Due 31 Jan 2027 9 months remaining
Confirmation Submitted 22 Apr 2026 Next due 1 May 2027 12 months remaining
Net assets £336K £335K 2025 year on year
Total assets £366K £362K 2025 year on year
Total Liabilities £29K £27K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for CELLESTIAL HEALTH LTD (14811694), an active company based in United Kingdom. Incorporated 18 Apr 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2024–2025)

Cash in Bank

£304.02k

Increased by £301.04k (+10119%)

Net Assets

£336.39k

Increased by £335.01k (+24241%)

Total Liabilities

£29.18k

Increased by £27.19k (+1369%)

Turnover

N/A

Employees

1

Debt Ratio

8%

Decreased by 51 (-86%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 44,885 Shares £250k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Nov 202430,599£250k£8.17
22 Oct 202414,286£0.143£0

Officers

Officers

3 active
Status
Grant, Stephen HamiltonDirectorAmericanUnited States663 Dec 2024Active
Hastings, Nataly, DrDirectorBritishEngland3318 Apr 2023Active
Pankova, Natalie, DrDirectorBritishEngland3722 Oct 2024Active

Shareholders

Shareholders (10)

Nataly Hastings
48.3%
85,714
Zinc 2 Llp
17.3%
30,599

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Nataly Hastings

British

Active
Notified 18 Apr 2023
Residence England
DOB April 1993
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Dr Nataly Hastings

British

Active
Notified 18 Apr 2023
Residence England
DOB April 1993
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Przemyslaw Aleksander Stempor

Ceased 4 Oct 2024

Ceased

Md Saifur Rahman

Ceased 4 Oct 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026Confirmation StatementConfirmation statement made on 17 Apr 2026 with updates
20 Apr 2026ResolutionResolutions
19 Apr 2026MiscellaneousReplacement filing of SH01 - 02/04/26 Statement of Capital gbp 1.83848
2 Apr 2026CapitalAllotment of shares (GBP 1.83848) on 2 Apr 2026
2 Apr 2026CapitalAllotment of shares (GBP 1.83848) on 2 Apr 2026
22 Apr 2026 Confirmation Statement

Confirmation statement made on 17 Apr 2026 with updates

20 Apr 2026 Resolution

Resolutions

19 Apr 2026 Miscellaneous

Replacement filing of SH01 - 02/04/26 Statement of Capital gbp 1.83848

2 Apr 2026 Capital

Allotment of shares (GBP 1.83848) on 2 Apr 2026

2 Apr 2026 Capital

Allotment of shares (GBP 1.83848) on 2 Apr 2026

Recent Activity

Latest Activity

Confirmation statement made on 17 Apr 2026 with updates

1 weeks ago on 22 Apr 2026

Resolutions

2 weeks ago on 20 Apr 2026

Replacement filing of SH01 - 02/04/26 Statement of Capital gbp 1.83848

2 weeks ago on 19 Apr 2026

Allotment of shares (GBP 1.83848) on 2 Apr 2026

1 months ago on 2 Apr 2026

Allotment of shares (GBP 1.83848) on 2 Apr 2026

1 months ago on 2 Apr 2026